Amdocs Target of Unusually High Options Trading (NASDAQ:DOX)

Amdocs Limited (NASDAQ:DOX) saw some unusual options trading on Wednesday. Stock traders bought 9,414 call options on the company. This represents an increase of 1,067% compared to the typical volume of 807 call options.

Amdocs Stock Performance

Shares of Amdocs stock traded up $0.14 on Wednesday, reaching $65.40. 316,302 shares of the stock were exchanged, compared to its average volume of 1,341,077. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23. Amdocs has a twelve month low of $63.33 and a twelve month high of $95.41. The firm has a market capitalization of $7.06 billion, a price-to-earnings ratio of 12.64, a PEG ratio of 1.15 and a beta of 0.42. The business has a 50 day moving average price of $70.74 and a two-hundred day moving average price of $77.44.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter in the prior year, the company earned $1.66 EPS. Amdocs’s quarterly revenue was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Analysts anticipate that Amdocs will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be issued a $0.569 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 annualized dividend and a dividend yield of 3.5%. Amdocs’s payout ratio is presently 43.91%.

Analyst Upgrades and Downgrades

DOX has been the topic of a number of research analyst reports. Stifel Nicolaus dropped their price target on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, Barclays cut their price target on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 4th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $92.33.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. LSV Asset Management raised its position in shares of Amdocs by 7.6% in the third quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock worth $299,376,000 after acquiring an additional 257,193 shares during the period. Illinois Municipal Retirement Fund grew its position in shares of Amdocs by 46.6% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 149,539 shares of the technology company’s stock valued at $12,270,000 after acquiring an additional 47,537 shares during the period. New York State Common Retirement Fund increased its stake in shares of Amdocs by 20.3% in the 3rd quarter. New York State Common Retirement Fund now owns 554,401 shares of the technology company’s stock valued at $45,489,000 after purchasing an additional 93,527 shares in the last quarter. Alps Advisors Inc. increased its stake in shares of Amdocs by 11.6% in the 3rd quarter. Alps Advisors Inc. now owns 237,883 shares of the technology company’s stock valued at $19,518,000 after purchasing an additional 24,771 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in Amdocs by 13.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 266,124 shares of the technology company’s stock worth $24,281,000 after purchasing an additional 31,827 shares during the period. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.